Regional heterogeneity changes in DCE-MRI as response to isolated limb perfusion in experimental soft-tissue sarcomas, Contrast Media & Molecular Imaging, vol.50, issue.11, pp.340-349, 2013. ,
DOI : 10.1088/0031-9155/50/11/L01
Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma, British Journal of Cancer, vol.11, issue.3, pp.455-60, 2015. ,
DOI : 10.1002/1097-0142(19880901)62:5<994::AID-CNCR2820620526>3.0.CO;2-4
Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer?, Annals of Oncology, vol.19, issue.4, pp.822-826, 2008. ,
DOI : 10.1093/annonc/mdn043
We Should Desist Using RECIST, at Least in GIST, Journal of Clinical Oncology, vol.25, issue.13, pp.1760-1764, 2007. ,
DOI : 10.1200/JCO.2006.07.3411
Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas, Journal of Nuclear Medicine, vol.49, issue.10, pp.1579-1584, 2008. ,
DOI : 10.2967/jnumed.108.053694
FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas, Clinical Cancer Research, vol.15, issue.8, pp.2856-2863, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2537
Radiographic and Histologic Response to Neoadjuvant Radiotherapy in Patients With Soft Tissue Sarcoma, Annals of Surgical Oncology, vol.76, issue.Suppl 2, pp.2578-84, 2010. ,
DOI : 10.1016/j.ijrobp.2009.03.015
Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria, Journal of Clinical Oncology, vol.25, issue.13, pp.1753-1762, 2007. ,
DOI : 10.1200/JCO.2006.07.3049
Modifications histologiques après chimiothérapie des sarcomes des tissus mous de l'adulte [Histological changes after chemotherapy of soft tissue sarcomas in the adult], Ann Pathol, vol.5, issue.2, pp.95-104, 1985. ,
Clinical, radiological and genetic features, associated with the histopathologic response to neoadjuvant chemotherapy (NAC) and outcomes in locally advanced soft tissue sarcoma (STS) patients (STS), Journal of Clinical Oncology, vol.35, pp.15-11014, 2017. ,
Detection of Soft-Tissue Sarcoma Recurrence: Added Value of Functional MR Imaging Techniques at 3.0 T, Radiology, vol.271, issue.2, pp.499-511, 2014. ,
DOI : 10.1148/radiol.13130844
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging, Annals of Oncology, vol.22, issue.3, pp.559-66, 2011. ,
DOI : 10.1093/annonc/mdq391
Osteogenic and Ewing Sarcomas: Estimation of Necrotic Fraction during Induction Chemotherapy with Dynamic Contrast-enhanced MR Imaging, Radiology, vol.228, issue.1, pp.271-279, 2003. ,
DOI : 10.1148/radiol.2281011651
Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing???s sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling, Magnetic Resonance Imaging, vol.18, issue.5, pp.525-560, 2000. ,
DOI : 10.1016/S0730-725X(00)00144-2
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-275, 2009. ,
DOI : 10.1016/j.ejca.2008.10.026
The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh, Cancer, vol.84, issue.5, pp.1005-1027, 1981. ,
DOI : 10.1148/110.3.541
Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas, Clinical Cancer Research, vol.14, issue.3, pp.715-720, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-1762
Myxoid/round cell and pleomorphic liposarcomas, Cancer, vol.103, issue.12, pp.2522-2553, 2007. ,
DOI : 10.1200/JCO.2005.04.160
URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.22720/pdf
BEST (Biomarkers, EndpointS, and other Tools) resource. NCBI http, 2016. ,
Radiomics: Images Are More than Pictures, They Are Data, Radiology, vol.278, issue.2, pp.563-77, 2016. ,
DOI : 10.1148/radiol.2015151169
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734157/pdf
MRI characteristics associated with high-grade myxoid liposarcoma, Clinical Radiology, vol.72, issue.7, pp.613-614, 2017. ,
DOI : 10.1016/j.crad.2017.01.016
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial, The Lancet Oncology, vol.18, issue.6, pp.812-822, 2017. ,
DOI : 10.1016/S1470-2045(17)30334-0
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study, The Lancet Oncology, vol.8, issue.7, pp.595-602, 2007. ,
DOI : 10.1016/S1470-2045(07)70175-4
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma., Journal of Clinical Oncology, vol.15, issue.1, pp.350-62, 1997. ,
DOI : 10.1200/JCO.1997.15.1.350
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacodynamic Biomarker Study of Sorafenib in Metastatic Renal Carcinoma, Journal of Clinical Oncology, vol.26, issue.28, pp.4572-4580, 2008. ,
DOI : 10.1200/JCO.2007.15.5655
Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma, Sarcoma, vol.14, issue.5, p.538085, 2011. ,
DOI : 10.1155/2007/36785
URL : https://doi.org/10.1155/2011/538085
Muscle edema in musculoskeletal tumors: MR imaging characteristics and clinical significance, Journal of Magnetic Resonance Imaging, vol.23, issue.4, pp.441-450, 1991. ,
DOI : 10.2214/ajr.151.2.231
Assessment of Osteosarcoma Response to Preoperative Chemotherapy Using Dynamic FLASH Gadolinium-DTPA-Enhanced Magnetic Resonance Mapping, Investigative Radiology, vol.27, issue.5, pp.367-73, 1992. ,
DOI : 10.1097/00004424-199205000-00010
18F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy, Clinical Cancer Research, vol.18, issue.7, pp.2024-2031, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-2139
URL : http://clincancerres.aacrjournals.org/content/clincanres/18/7/2024.full.pdf
Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients, Investigational New Drugs, vol.13, issue.suppl 2, pp.529-559, 2010. ,
DOI : 10.1007/s10637-009-9262-4
Evaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Tomography, vol.2, issue.4, pp.308-316, 2016. ,
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study, The Lancet Oncology, vol.11, issue.6, pp.561-70, 2010. ,
DOI : 10.1016/S1470-2045(10)70071-1
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517819/pdf
Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Clinical Cancer Research, vol.13, issue.12, pp.3449-59, 2007. ,
DOI : 10.1158/1078-0432.CCR-07-0238
URL : http://clincancerres.aacrjournals.org/content/clincanres/13/12/3449.full.pdf
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival, Annals of Oncology, vol.20, issue.9 ,
DOI : 10.1093/annonc/mdp029
Tumour volume changes following pre-operative radiotherapy in borderline resectable limb and trunk soft tissue sarcoma, European Journal of Surgical Oncology (EJSO), vol.40, issue.4, pp.394-401, 2014. ,
DOI : 10.1016/j.ejso.2014.01.011
T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer, European Radiology, vol.21, issue.1, pp.253-61, 2013. ,
DOI : 10.1007/s00330-011-2220-5
Radiomics: the process and the challenges, Magnetic Resonance Imaging, vol.30, issue.9, pp.1234-1282, 2012. ,
DOI : 10.1016/j.mri.2012.06.010
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563280/pdf
Radiomics: Extracting more information from medical images using advanced feature analysis, European Journal of Cancer, vol.48, issue.4, pp.441-447, 2012. ,
DOI : 10.1016/j.ejca.2011.11.036
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533986/pdf
The Measurement of Observer Agreement for Categorical Data, Biometrics, vol.33, issue.1, pp.159-74, 1977. ,
DOI : 10.2307/2529310
Simulating the effect of input errors on the accuracy of Tofts??? pharmacokinetic model parameters, Magnetic Resonance Imaging, vol.33, issue.2, pp.222-257, 2015. ,
DOI : 10.1016/j.mri.2014.10.004
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging, European Radiology, vol.37, issue.7, pp.1451-64, 2012. ,
DOI : 10.1007/s00259-010-1448-7
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology, Annals of Oncology, vol.28, issue.6, pp.1191-1206, 2017. ,
DOI : 10.1093/annonc/mdx034
URL : https://hal.archives-ouvertes.fr/hal-01648559
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Pharmacodynamic Measure of Response After Acute Dosing of AG-013736, an Oral Angiogenesis Inhibitor, in Patients With Advanced Solid Tumors: Results From a Phase I Study, Journal of Clinical Oncology, vol.23, issue.24, pp.5464-73, 2005. ,
DOI : 10.1200/JCO.2005.04.143
Histologic Alterations from Neoadjuvant Chemotherapy in High-Grade Extremity Soft Tissue Sarcoma: Clinicopathological Correlation, The Oncologist, vol.13, issue.4, pp.451-459, 2008. ,
DOI : 10.1634/theoncologist.2007-0220
URL : http://theoncologist.alphamedpress.org/content/13/4/451.full.pdf
Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates, Clinical Cancer Research, vol.19, issue.24, pp.6902-6913, 2013. ,
DOI : 10.1158/1078-0432.CCR-13-1594
Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer ??? Soft Tissue and Bone Sarcoma Group (EORTC ??? STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging, European Journal of Cancer, vol.56, pp.37-44, 2016. ,
DOI : 10.1016/j.ejca.2015.12.008
Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI, Anticancer Res, vol.32, issue.11, pp.4951-61, 2012. ,
Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies, Journal of Clinical Oncology, vol.21, issue.21, pp.3955-64, 2003. ,
DOI : 10.1200/JCO.2003.08.092
Automatic selection of arterial input function using cluster analysis, Magnetic Resonance in Medicine, vol.52, issue.3, pp.524-555, 2006. ,
DOI : 10.1016/S0140-6736(86)90837-8
Multiparametric Imaging of Tumor Response to Therapy, Radiology, vol.256, issue.2, pp.348-64, 2010. ,
DOI : 10.1148/radiol.10091760
Advanced Noncontrast MR Imaging in Musculoskeletal Radiology, Radiologic Clinics of North America, vol.53, issue.3, pp.549-67, 2015. ,
DOI : 10.1016/j.rcl.2015.01.005
Neoadjuvant treatment, Current Opinion in Oncology, vol.29, issue.4, pp.253-259, 2017. ,
DOI : 10.1097/CCO.0000000000000372
The Inconsistency of ???Optimal??? Cutpoints Obtained using Two Criteria based on the Receiver Operating Characteristic Curve, American Journal of Epidemiology, vol.163, issue.7, pp.670-675, 2006. ,
DOI : 10.1093/aje/kwj063
Dynamic contrast-enhanced MR imaging evaluation of osteosarcoma response to neoadjuvant chemotherapy, Journal of Magnetic Resonance Imaging, vol.4, issue.6, pp.689-94, 1995. ,
DOI : 10.1148/radiology.184.1.1319075
Chemotherapy in alveolar soft part sarcomas, European Journal of Cancer, vol.39, issue.11, pp.1511-1517, 2003. ,
DOI : 10.1016/S0959-8049(03)00264-8
Dynamic contrast-enhanced MRI in mice: An investigation of model parameter uncertainties, Magnetic Resonance in Medicine, vol.24, issue.5, pp.1979-87, 2015. ,
DOI : 10.1002/nbm.1648
Morphological grades of regression in osteosarcoma after polychemotherapy ? Study COSS 80, Journal of Cancer Research and Clinical Oncology, vol.106, issue.S1, pp.21-25, 1983. ,
DOI : 10.1007/BF00625047
(Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair, European Journal of Cancer, vol.70, pp.1-11, 2017. ,
DOI : 10.1016/j.ejca.2016.09.030
The intriguing patterns of tumor response to trabectedin, Expert Review of Anticancer Therapy, vol.13, issue.sup1, pp.21-25, 2013. ,
DOI : 10.1634/theoncologist.13-S2-4
Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences, Radiology, vol.278, issue.3, pp.831-871, 2016. ,
DOI : 10.1148/radiol.2015142463
High-Grade Soft-Tissue Sarcomas: Tumor Response Assessment???Pilot Study to Assess the Correlation between Radiologic and Pathologic Response by Using RECIST and Choi Criteria, Radiology, vol.251, issue.2, pp.447-56, 2009. ,
DOI : 10.1148/radiol.2512081403
Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy, Cancer, vol.113, issue.18S, pp.5857-66, 2012. ,
DOI : 10.1002/cncr.23592
Metrology Standards for Quantitative Imaging Biomarkers, Radiology, vol.277, issue.3, pp.813-825, 2015. ,
DOI : 10.1148/radiol.2015142202
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666097/pdf
Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols, Journal of Magnetic Resonance Imaging, vol.10, issue.3, pp.223-255, 1999. ,
DOI : 10.1002/(SICI)1522-2586(199909)10:3<221::AID-JMRI1>3.0.CO;2-X
Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system, International Journal of Cancer, vol.2, issue.1, pp.37-42, 1984. ,
DOI : 10.1002/ijc.2910330108
Osteosarcoma, Investigative Radiology, vol.41, issue.8, pp.618-641, 2006. ,
DOI : 10.1097/01.rli.0000225398.17315.68
Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results, European Radiology, vol.13, issue.8, pp.1849-58, 2003. ,
DOI : 10.1007/s00330-002-1785-4
Soft-Tissue Tumors: Value of Static and Dynamic Gadopentetate Dimeglumine???enhanced MR Imaging in Prediction of Malignancy, Radiology, vol.233, issue.2, pp.493-502, 2004. ,
DOI : 10.1148/radiol.2332031110
Dynamic Contrast-enhanced Magnetic Resonance Imaging as a Predictor of Clinical Outcome in Canine Spontaneous Soft Tissue Sarcomas Treated with Thermoradiotherapy, Clinical Cancer Research, vol.15, issue.15, pp.4993-5001, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-2222
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer???Soft Tissue and Bone Sarcoma Group (EORTC???STBSG) recommendations for pathological examination and reporting, European Journal of Cancer, vol.53, pp.84-95, 2016. ,
DOI : 10.1016/j.ejca.2015.09.021
Histologic assessment of peritumoral edema in soft tissue sarcoma, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.5 ,
DOI : 10.1016/j.ijrobp.2004.08.036
Synergistic role of simultaneous PET/MRI-MRS in soft tissue sarcoma metabolism imaging, Magnetic Resonance Imaging, vol.34, issue.3, pp.276-285, 2016. ,
DOI : 10.1016/j.mri.2015.10.027